Centric Health Corp. (TSE:CRX – Free Report) – Analysts at Desjardins issued their Q2 2024 earnings estimates for Centric Health in a research note issued to investors on Monday, July 29th. Desjardins analyst G. Ho expects that the company will earn ($0.01) per share for the quarter.
Centric Health Stock Performance
Centric Health (TSE:CRX – Get Free Report) last announced its earnings results on Friday, May 10th. The company reported C($0.01) EPS for the quarter, beating analysts’ consensus estimates of C($0.02) by C$0.01. The business had revenue of C$89.73 million during the quarter, compared to analysts’ expectations of C$89.80 million.
See Also
- Five stocks we like better than Centric Health
- Stocks with Unusual Volume: How to Find Unusual Volume Stocks in Real Time
- First Solar Stock: The Dawn of a New Rally in Share Prices
- How to Invest in Insurance Companies: A Guide
- Mastercard Stock’s Q2 Financial Results Outshine Competitors
- 3 Warren Buffett Stocks to Buy Now
- Tobacco Giant’s Shares Fall on EPS Miss, Lackluster Pouch Gains
Receive News & Ratings for Centric Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centric Health and related companies with MarketBeat.com's FREE daily email newsletter.
